These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 36428703)

  • 1. Caprin-1 plays a role in cell proliferation and Warburg metabolism of esophageal carcinoma by regulating METTL3 and WTAP.
    Gao Y; Yuan L; Ke C; Pei Z; Liu X; Wu R; Kui X; Zhang Y
    J Transl Med; 2023 Feb; 21(1):159. PubMed ID: 36855123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDKL3 shapes immunosuppressive tumor microenvironment and initiates autophagy in esophageal cancer.
    Bi Y; Liu J; Qin S; Ji F; Zhou C; Yang H; Zhou S
    Front Immunol; 2024; 15():1295011. PubMed ID: 38562942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PITPNC1 Suppress CD8
    Liang J; Liao L; Xie L; Tang W; Yu X; Lu Y; Chen H; Xu J; Sun L; Wu H; Cui C; Tan Y
    J Transl Med; 2024 Jan; 22(1):117. PubMed ID: 38291470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly Expressed Z-DNA Binding Protein 1 in Esophageal Cancer Promotes Tumor Growth.
    Wusiman S; Liu Y; Li H; Deng Y; Qu X; Tuerxun H; Liu L
    Dig Dis Sci; 2024 May; 69(5):1674-1690. PubMed ID: 38507125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSMA7 promotes the malignant proliferation of esophageal cancer.
    Jiao QH; Wang Y; Zhang AN; Liu QQ; Zhou QB
    Heliyon; 2024 Jan; 10(1):e23173. PubMed ID: 38173490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PBF, a Proto-oncogene in Esophageal Carcinoma.
    Lian SH; Song JD; Huang Y
    Open Med (Wars); 2019; 14():748-756. PubMed ID: 31637306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroartemisinin suppresses the tumorigenesis of esophageal carcinoma by elevating DAB2IP expression in a NFIC-dependent manner.
    Yang C; Wei W; Hu F; Zhao X; Yang H; Song X; Sun Z
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; ():. PubMed ID: 38789636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANOS1 accelerates the progression of esophageal cancer identified by multi-omic approaches.
    Zhu Z; Dong S; Qin S; Gu K; Zhou Y
    Am J Cancer Res; 2024; 14(5):2343-2370. PubMed ID: 38859828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of esophageal cancer progression through HACE1-TRIP12 interaction and associated RAC1 ubiquitination and degradation.
    Hu Y; Zhu Z; Xu Y; Zaman MF; Ge Y; Hu J; Tang X
    J Cancer; 2024; 15(10):3114-3127. PubMed ID: 38706891
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification and Characterization of PrognosticMacrophage Subpopulations for HumanEsophagealCarcinoma.
    Li P; Gao X; Huang D; Gu X
    Curr Med Chem; 2024 Feb; ():. PubMed ID: 38362682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using single-cell RNA sequencing and bulk RNA sequencing data to reveal a correlation between smoking and neutrophil activation in esophageal carcinoma patients.
    Ba Y; Gu X
    Environ Toxicol; 2024 May; ():. PubMed ID: 38700434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial gene expression analysis of healthy and cancerous esophagus uncovers bacterial biomarkers of clinical outcomes.
    Schäffer DE; Li W; Elbasir A; Altieri DC; Long Q; Auslander N
    ISME Commun; 2023 Dec; 3(1):128. PubMed ID: 38049632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDC73 serves as a tumour-promoting factor in oesophageal cancer.
    Song J; Guo W; Xu H; Gao T
    Heliyon; 2024 May; 10(9):e29904. PubMed ID: 38707440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral CXCR4
    Lu Z; Wang X; Feng J; Chai W; Wang W; Wang Q; Yang S; Yang W; Su Y; Mou W; Peng Y; Wang H; Gui J
    Front Immunol; 2024; 15():1363454. PubMed ID: 38487536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Esophageal Adenocarcinoma.
    Yang C; Cao F; He Y
    Med Sci Monit; 2023 Aug; 29():e940157. PubMed ID: 37632137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD155 Cooperates with PD-1/PD-L1 to Promote Proliferation of Esophageal Squamous Cancer Cells via PI3K/Akt and MAPK Signaling Pathways.
    Tang X; Yang J; Shi A; Xiong Y; Wen M; Luo Z; Tian H; Zheng K; Liu Y; Shu C; Ma N; Wang R; Zhao J
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRDX2 plays an oncogenic role in esophageal squamous cell carcinoma via Wnt/β-catenin and AKT pathways.
    Feng AL; Han X; Meng X; Chen Z; Li Q; Shu W; Dai H; Zhu J; Yang Z
    Clin Transl Oncol; 2020 Oct; 22(10):1838-1848. PubMed ID: 32130676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 19. Knockdown of NOLC1 Inhibits PI3K-AKT Pathway to Improve the Poor Prognosis of Esophageal Carcinoma.
    Kong F; Shang Y; Diao X; Huang J; Liu H
    J Oncol; 2021; 2021():9944132. PubMed ID: 34046062
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.